DIMENSIONAL FUND ADVISORS LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$8,621,751
-52.0%
171,663
-39.5%
0.00%
-50.0%
Q2 2023$17,951,976
+29.5%
283,970
-7.8%
0.01%
+20.0%
Q1 2023$13,860,486
+88352.4%
308,101
-13.9%
0.01%0.0%
Q4 2022$15,670
-99.9%
357,731
-17.7%
0.01%
-54.5%
Q3 2022$28,626,000
+6.1%
434,456
-18.7%
0.01%
+10.0%
Q2 2022$26,981,000
-23.8%
534,110
-3.7%
0.01%
-9.1%
Q1 2022$35,422,000
-27.6%
554,480
+21.4%
0.01%
-26.7%
Q4 2021$48,945,000
+69.4%
456,923
+62.6%
0.02%
+66.7%
Q3 2021$28,894,000
+411.3%
281,027
+337.4%
0.01%
+350.0%
Q2 2021$5,651,000
-4.9%
64,249
+5.1%
0.00%0.0%
Q1 2021$5,945,000
-20.7%
61,117
-8.6%
0.00%
-33.3%
Q4 2020$7,499,000
+88.8%
66,862
+56.1%
0.00%
+50.0%
Q3 2020$3,971,000
+1611.6%
42,833
+1342.7%
0.00%
Q2 2020$232,000
-83.8%
2,969
-87.9%
0.00%
-100.0%
Q1 2020$1,429,000
-28.9%
24,439
-2.6%
0.00%0.0%
Q4 2019$2,011,000
+7.1%
25,097
-1.8%
0.00%0.0%
Q3 2019$1,878,000
+115.4%
25,559
+176.6%
0.00%
Q2 2019$872,000
-10.2%
9,241
-23.8%
0.00%
Q1 2019$971,000
-28.2%
12,135
-51.6%
0.00%
-100.0%
Q4 2018$1,352,000
-65.7%
25,077
-41.6%
0.00%
-50.0%
Q1 2018$3,940,00042,9650.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders